Potentiating antilymphoma efficacy of chemotherapy using a liposome for integration of CD20 targeting, ultra-violet irradiation polymerizing, and controlled drug delivery

Nanoscale Research Letters

Volumn 9, Issue 1, 2014, Pages

  Wu, Cong ^a   Li, Huafei ^a   Zhao, He ^b   Zhang, Weiwei ^a   Chen, Yan ^a   Yue, Zhanyi ^a   Lu, Qiong ^a   Wan, Yuxiang ^a   Tian, Xiaoyu ^a   Deng, Anmei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Chemotherapy; Liposomes; Non Hodgkin lymphoma; Rituximab; Serum stability; Ultra violet irradiation polymerizing

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; CHEMOTHERAPY; IRRADIATION; LIPOSOMES; MAMMALS; ONCOLOGY; PHARMACODYNAMICS; STABILITY; TARGETED DRUG DELIVERY;

ENHANCED PERMEABILITY AND RETENTION EFFECTS; HEMATOLOGICAL MALIGNANCIES; INHIBITORY CONCENTRATION; INTERMOLECULAR CROSSLINKING; NON-HODGKIN LYMPHOMA; RITUXIMAB; SERUM STABILITY; ULTRAVIOLET IRRADIATIONS;

CONTROLLED DRUG DELIVERY;

MUS;

EID: 84919933053     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-9-447     Document Type: Article

References (44)

1. Shankland KR, Armitage JO, Hancock BW: Non-Hodgkin lymphoma.Lancet 2012, 380:848–857. 10.1016/S0140-6736(12)60605-9
2. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R: B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.Cell 1991, 67:1075–1087. 10.1016/0092-8674(91)90285-7
3. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R: Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.Cell 2010, 142:699–713. 10.1016/j.cell.2010.07.044
4. Moncada B, Sobrevilla-Ondarza S, Md JD: Radiotherapy supports a better outcome than chemotherapy in cutaneous natural killer (NK)/T cell lymphoma nasal type.Int J Dermatol 2013, 52:1276–1277.
5. Reimer P, Chawla S: Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral T-cell lymphoma.J Hematol Oncol 2013, 6:69. 10.1186/1756-8722-6-69
6. Kim SJ, Kang HJ, Kim JS, Oh SY, Choi CW, Lee SI, Won JH, Kim MK, Kwon JH, Mun YC, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Park J, Oh S, Huh J, Ko YH, Suh C, Kim WS: Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone.Blood 2011, 117:1958–1965. 10.1182/blood-2010-06-288480
7. Ganta S, Devalapally H, Shahiwala A, Amiji M: A review of stimuli-responsive nanocarriers for drug and gene delivery.J Control Release 2008, 126:187–204. 10.1016/j.jconrel.2007.12.017
8. Dickerson EB, Blackburn WH, Smith MH, Kapa LB, Lyon LA, McDonald JF: Chemosensitization of cancer cells by siRNA using targeted nanogel delivery.BMC Cancer 2010, 10:10. 10.1186/1471-2407-10-10
9. Kang CM, Koo HJ, Lee S, Lee KC, Oh YK, Choe YS: 64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesis.Nucl Med Biol 2013, 40:1018–1024. 10.1016/j.nucmedbio.2013.08.003
10. Zhang R, Luo K, Yang J, Sima M, Sun Y, Janat-Amsbury MM, Kopecek J: Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.J Control Release 2013, 166:66–74. 10.1016/j.jconrel.2012.12.009
11. Sheng R, Xia K, Chen J, Xu Y, Cao A: Terminal modification on mPEG-dendritic poly-(l)-lysine cationic diblock copolymer for efficient gene delivery.J Biomater Sci Polym Ed 2013, 24:1935–1951. 10.1080/09205063.2013.811008
12. Biswas S, Deshpande PP, Perche F, Dodwadkar NS, Sane SD, Torchilin VP: Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer.Cancer Lett 2013, 335:191–200. 10.1016/j.canlet.2013.02.020
13. Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D: Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.Pharmacol Rev 1999, 51:691–743.
14. Seymour LW: Passive tumor targeting of soluble macromolecules and drug conjugates.Crit Rev Ther Drug Carrier Syst 1992, 9:135–187.
15. Maeda H, Matsumura Y: Tumoritropic and lymphotropic principles of macromolecular drugs.Crit Rev Ther Drug Carrier Syst 1989, 6:193–210.
16. Iyer AK, Khaled G, Fang J, Maeda H: Exploiting the enhanced permeability and retention effect for tumor targeting.Drug Discov Today 2006, 11:812–818. 10.1016/j.drudis.2006.07.005
17. Li W, Li H, Li J, Wang H, Zhao H, Zhang L, Xia Y, Ye Z, Gao J, Dai J, Wang H, Guo Y: Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors.Int J Nanomedicine 2012, 7:4661–4677.
18. Wang P, Zhao XH, Wang ZY, Meng M, Li X, Ning Q: Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment.Cancer Lett 2010, 298:34–49. 10.1016/j.canlet.2010.06.001
19. Gabizon AA: Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes.Cancer Res 1992, 52:891–896.
20. Zheng J, Jaffray D, Allen C: Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model.Mol Pharm 2009, 6:571–580. 10.1021/mp800234r
21. Stapleton S, Allen C, Pintilie M, Jaffray DA: Tumor perfusion imaging predicts the intra-tumoral accumulation of liposomes.J Control Release 2013, 172:351–357. 10.1016/j.jconrel.2013.08.296
22. Bhat SA, Czuczman MS: Novel antibodies in the treatment of non-Hodgkin's lymphoma.Neth J Med 2009, 67:311–321.
23. Maruyama D: Novel monoclonal antibodies for the treatment of malignant lymphomas.Rinsho Ketsueki 2011, 52:618–626.
24. Kano MR, Bae Y, Iwata C, Morishita Y, Yashiro M, Oka M, Fujii T, Komuro A, Kiyono K, Kaminishi M, Hirakawa K, Ouchi Y, Nishiyama N, Kataoka K, Miyazono K: Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling.Proc Natl Acad Sci U S A 2007, 104:3460–3465. 10.1073/pnas.0611660104
25. Li W, Zhao H, Qian W, Li H, Zhang L, Ye Z, Zhang G, Xia M, Li J, Gao J, Li B, Kou G, Dai J, Wang H, Guo Y: Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles.Biomaterials 2012, 33:5349–5362. 10.1016/j.biomaterials.2012.04.016
26. Temprana CF, Duarte EL, Taira MC, Lamy MT, Del VAS: Structural characterization of photopolymerizable binary liposomes containing diacetylenic and saturated phospholipids.Langmuir 2010, 26:10084–10092. 10.1021/la100214v
27. Wagner N, Dose K, Koch H, Ringsdorf H: Incorporation of ATP synthetase into long-term stable liposomes of a polymerizable synthetic sulfolipid.Febs Lett 1981, 132:313–318. 10.1016/0014-5793(81)81187-8
28. Huwyler J, Wu D, Pardridge WM: Brain drug delivery of small molecules using immunoliposomes.Proc Natl Acad Sci U S A 1996, 93:14164–14169. 10.1073/pnas.93.24.14164
29. Giacomelli C, Le Men L, Borsali R, Lai-Kee-Him J, Brisson A, Armes SP, Lewis AL: Phosphorylcholine-based pH-responsive diblock copolymer micelles as drug delivery vehicles: light scattering, electron microscopy, and fluorescence experiments.Biomacromolecules 2006, 7:817–828. 10.1021/bm0508921
30. Yoshimura T, Esumi K: Physicochemical properties of anionic triple-chain surfactants in alkaline solutions.J Colloid Interface Sci 2004, 276:450–455. 10.1016/j.jcis.2004.03.069
31. Tuscano JM, Martin SM, Ma Y, Zamboni W, O'Donnell RT: Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model.Clin Cancer Res 2010, 16:2760–2768. 10.1158/1078-0432.CCR-09-3199
32. Zhang Y, Huo M, Zhou J, Xie S: PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.Comput Methods Programs Biomed 2010, 99:306–314. 10.1016/j.cmpb.2010.01.007
33. Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ: Survival analysis I: the Kaplan-Meier method.Nephron Clin Pract 2011, 119:c83-c88. 10.1159/000324758
34. Ziegler A, Lange S, Bender R: Survival analysis: properties and Kaplan-Meier method.Dtsch Med Wochenschr 2007,132(Suppl 1):e36-e38.
35. Kozlowska D, Biswas S, Fox EK, Wu B, Bolster F, Edupuganti OP, Torchilin V, Eustace S, Botta M, O'Kennedy R, Brougham DF: Gadolinium-loaded polychelating amphiphilic polymer as an enhanced MRI contrast agent for human multiple myeloma and non Hodgkin's lymphoma (human Burkitt's lymphoma).RSC Adv 2014, 4:18007–18016. 10.1039/c3ra45400b
36. Glennie MJ, French RR, Cragg MS, Taylor RP: Mechanisms of killing by anti-CD20 monoclonal antibodies.Mol Immunol 2007, 44:3823–3837. 10.1016/j.molimm.2007.06.151
37. Wu Y, Yang Y, Zhang FC, Wu C, Lu WL, Mei XG: Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals.J Liposome Res 2011, 21:221–228. 10.3109/08982104.2010.520273
38. Abu LA, Nawata K, Shimizu T, Ishida T, Kiwada H: Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.Int J Pharm 2013, 456:235–242. 10.1016/j.ijpharm.2013.07.059
39. Shahin M, Soudy R, Aliabadi HM, Kneteman N, Kaur K, Lavasanifar A: Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.Biomaterials 2013, 34:4089–4097. 10.1016/j.biomaterials.2013.02.019
40. Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.Cancer Res 1986, 46:6387–6392.
41. See YP, Carlsen SA, Till JE, Ling V: Increased drug permeability in Chinese hamster ovary cells in the presence of cyanide.Biochim Biophys Acta 1974, 373:242–252. 10.1016/0005-2736(74)90148-5
42. Choi KM, Kwon IC, Ahn HJ: Self-assembled amphiphilic DNA-cholesterol/DNA-peptide hybrid duplexes with liposome-like structure for doxorubicin delivery.Biomaterials 2013, 34:4183–4190. 10.1016/j.biomaterials.2013.02.044
43. Yuba E, Harada A, Sakanishi Y, Watarai S, Kono K: A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy.Biomaterials 2013, 34:3042–3052. 10.1016/j.biomaterials.2012.12.031
44. Molavi O, Xiong XB, Douglas D, Kneteman N, Nagata S, Pastan I, Chu Q, Lavasanifar A, Lai R: Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma.Biomaterials 2013, 34:8718–8725. 10.1016/j.biomaterials.2013.07.068